Tofacitinib citrate 540737-29-9 Rheumatoid arthritis-ka ka hortagga kansarka
Lacag bixintaT/T, L/C
Asal ahaan badeecada:Shiinaha
Dekadda Rarida:Beijing/Shanghai/Hangzhou
Awoodda wax-soo-saarka:100kg/bishii
Dalbo (MOQ):25kg
Waqtiga Hogaaminta:3 Maalmo Shaqo
Xaaladda kaydinta:Lagu kaydiyaa qabow, meel qalalan, heerkulka qolka.
Qalabka xirmada:durbaan
Cabbirka xirmada:25kg/durbaan
Macluumaadka badbaadada:Maaha alaab khatar ah
Hordhac
Tofacitinib, waa daawo loo isticmaalo daawaynta rheumatoid arthritis-ka, psoriatic arthritis, iyo ulcerative colitis.
Tofacitinib citrate waxaa loo isticmaalaa in lagu daweeyo dadka qaangaarka ah ee qaba xanuunka rheumatoid arthritis-ka dhexdhexaad ah ama aad u daran kuwaas oo ka helay jawaab celin ku filan, ama aan u dulqaadan karin, methotrexate.
Tofacitinib citrate waxaa loo tilmaamaa daawaynta rheumatoid arthritis-ka ee dhexdhexaadka ah ama daran ee dadka qaangaarka ah ee si aan ku filneyn uga jawaabin, ama aan u dulqaadan hal ama ka badan oo ah daawooyinka wax ka beddelaya daawooyinka ka hortagga rheumatic.
Faahfaahin (guriga dhexdiisa)
| Shayga | Tilmaamid |
| Muuqashada | Budada crystalline cad ama ka baxsan |
| Aqoonsiga | IR, HPLC |
| Biyo | ≤1.5% |
| Walxaha laxidhiidha | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib fuuqbaxday ≤0.15% | |
| Mid kasta oo wasakh ah oo aan la garanayn ≤0.10% | |
| Wadarta wasakhda: ≤1.0% | |
| Xalalka Haraaga ah | Ethanol ≤5000ppm |
| Benzene ≤2pm | |
| Toluene ≤890ppm | |
| Chlroethane ≤1000ppm | |
| N,N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| dambaska sulphateed | ≤0.1% |
| Birta culus | ≤10pm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| Qiimaynta (ku salaysan anhydrous) 98.0-102.0% |
